BR0114665A - Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio - Google Patents

Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio

Info

Publication number
BR0114665A
BR0114665A BR0114665-3A BR0114665A BR0114665A BR 0114665 A BR0114665 A BR 0114665A BR 0114665 A BR0114665 A BR 0114665A BR 0114665 A BR0114665 A BR 0114665A
Authority
BR
Brazil
Prior art keywords
antiprogestins
treatment
dependent diseases
prophylaxis
hormone dependent
Prior art date
Application number
BR0114665-3A
Other languages
English (en)
Inventor
Jens Hoffmann
Rosemarie Lichtner
Gerhard Siemeister
Martin Schneider
Ulrike Fuhrmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR0114665A publication Critical patent/BR0114665A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DE ANTIPROGESTINAS PARA A PROFILAXIA E TRATAMENTO DE DOENçAS DEPENDENTES DE HORMÈNIO". A presente invenção refere-se a métodos e usos para prevenir ou tratar uma doença dependente de hormónio, em particular, o câncer de mama, em um mamífero, através de antiprogestinas, em particular a antiprogestina 11<225>-(4-acetilfenil)-17<225>-hidróxi-17<244>-(1,1,2,2,2-pentaflu oretil)-estra-4,9-dien-3-ona ou um derivado ou análogo farmaceuticamente aceitável dela. A invenção refere-se também a composições farmacêuticas contendo a referida antiprogestina.
BR0114665-3A 2000-10-18 2001-10-17 Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio BR0114665A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24099800P 2000-10-18 2000-10-18
EP00250341 2000-10-18
PCT/EP2001/012005 WO2002032430A1 (en) 2000-10-18 2001-10-17 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases

Publications (1)

Publication Number Publication Date
BR0114665A true BR0114665A (pt) 2004-01-13

Family

ID=26072951

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114665-3A BR0114665A (pt) 2000-10-18 2001-10-17 Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio

Country Status (26)

Country Link
US (1) US7378406B2 (pt)
EP (1) EP1328276B1 (pt)
JP (2) JP2004511522A (pt)
KR (1) KR100632908B1 (pt)
CN (1) CN1512886A (pt)
AT (1) ATE310522T1 (pt)
AU (2) AU1824302A (pt)
BG (1) BG107743A (pt)
BR (1) BR0114665A (pt)
CA (1) CA2423017C (pt)
CY (1) CY1104981T1 (pt)
CZ (1) CZ299942B6 (pt)
DE (1) DE60115274T2 (pt)
DK (1) DK1328276T3 (pt)
EE (1) EE05259B1 (pt)
ES (1) ES2253443T3 (pt)
HR (1) HRP20030387A2 (pt)
HU (1) HUP0301460A3 (pt)
IL (2) IL154975A0 (pt)
MX (1) MXPA03002954A (pt)
NO (1) NO20031740L (pt)
NZ (1) NZ538346A (pt)
PL (1) PL360151A1 (pt)
SI (1) SI1328276T1 (pt)
SK (1) SK287124B6 (pt)
WO (1) WO2002032430A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27301A1 (es) * 2001-05-25 2003-02-28 Schering Ag Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata
DE10159217A1 (de) 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
US20040242551A1 (en) * 2003-05-28 2004-12-02 Schering Ag Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
US9517240B2 (en) * 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US20080261929A1 (en) * 2007-04-23 2008-10-23 Jens Hoffmann Combination of progesterone-receptor antagonist together with an aromatase inhibitor for use in brca mediated diseases
JP2010524997A (ja) * 2007-04-23 2010-07-22 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト Ｂｒｃａ単独での、又は抗エストロゲン薬を伴った組み合わせ物としての使用のためのプロゲステロン受容体拮抗薬
US20080268041A1 (en) * 2007-04-23 2008-10-30 Jens Hoffmann Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
TWI477276B (zh) * 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
TWI539953B (zh) * 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
JP5894143B2 (ja) * 2010-03-22 2016-03-23 リプロス セラピューティクス インコーポレイテッド 抗黄体ホルモンの無毒送達のための組成物および方法
NZ702467A (en) 2012-05-31 2016-07-29 Repros Therapeutics Inc Formulations and methods for vaginal delivery of antiprogestins
CN104755087A (zh) 2012-11-02 2015-07-01 利普生物药剂公司 治疗孕酮依赖性病况的方法和组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE19706061A1 (de) 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette

Also Published As

Publication number Publication date
IL154975A (en) 2007-05-15
EP1328276A1 (en) 2003-07-23
ES2253443T3 (es) 2006-06-01
JP2004511522A (ja) 2004-04-15
HUP0301460A2 (hu) 2003-10-28
SI1328276T1 (sl) 2006-04-30
ATE310522T1 (de) 2005-12-15
US20040048841A1 (en) 2004-03-11
WO2002032430A1 (en) 2002-04-25
DE60115274D1 (de) 2005-12-29
CN1512886A (zh) 2004-07-14
JP2010077158A (ja) 2010-04-08
KR100632908B1 (ko) 2006-10-13
EP1328276B1 (en) 2005-11-23
CY1104981T1 (el) 2010-03-03
AU1824302A (en) 2002-04-29
EE200300155A (et) 2003-08-15
HRP20030387A2 (en) 2005-04-30
US7378406B2 (en) 2008-05-27
KR20030044007A (ko) 2003-06-02
AU2002218243B2 (en) 2006-07-13
CZ299942B6 (cs) 2008-12-29
SK287124B6 (sk) 2009-12-07
SK4742003A3 (en) 2004-09-08
NO20031740L (no) 2003-06-17
CA2423017A1 (en) 2002-04-25
HUP0301460A3 (en) 2010-01-28
EE05259B1 (et) 2010-02-15
BG107743A (bg) 2004-01-30
NO20031740D0 (no) 2003-04-15
DK1328276T3 (da) 2006-04-03
CA2423017C (en) 2009-01-06
PL360151A1 (en) 2004-09-06
NZ538346A (en) 2007-03-30
MXPA03002954A (es) 2003-08-07
DE60115274T2 (de) 2006-07-27
IL154975A0 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
BR0114665A (pt) Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio
BR0015974A (pt) Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto
NZ592039A (en) Combination therapy for the treatment of ocular neovascular disorders
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
DK0402950T3 (da) Behandling af postmenopausale ulemper
EA201201221A1 (ru) Фармацевтическая композиция для контрацепции и заместительной гормональной терапии
WO2006053172A3 (en) The use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune diseases
BR0008699A (pt) Combinações de formoterol e furoato demometasona para asma
MEP38008A (en) Drospirenone for hormone replacement therapy
EA200301022A1 (ru) Гормональная заместительная терапия
BRPI0416275A (pt) métodos de tratar, controlar ou prevenir um cáncer especìfico e uma doença associada com angiogênese indesejada
BRPI0410707A (pt) composição que compreende antagonistas de receptores de progesterona e antiestrogênios puros para a profilaxia e tratamento de doenças dependentes de hormÈnios
BR0114696A (pt) Uso de antiprogestinas para a indução de apoptose em uma célula
IS2702B (is) Notkun á (11beta, 17beta)-11-(1,3-bensódíoxól-5-ýl)-17-hýdroxý-17-(1-própýnýl)-estra-4,9-díen-3-ón í meðhöndluninni á alvarlegri geðdeyfðartruflun
YU30103A (sh) Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti
TW200733955A (en) Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
RU1789216C (ru) Состав, обладающий контрацептивным действием

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.